Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Accumulated Depreciation (2016 - 2025)

Ocular Therapeutix has reported Accumulated Depreciation over the past 12 years, most recently at $27.5 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation at $27.5 million for Q4 2025, up 16.45% from a year ago — trailing twelve months through Dec 2025 was $27.5 million (up 16.45% YoY), and the annual figure for FY2025 was $27.5 million, up 16.45%.
  • Accumulated Depreciation for Q4 2025 was $27.5 million at Ocular Therapeutix, up from $23.6 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation for OCUL hit a ceiling of $27.5 million in Q4 2025 and a floor of $15.2 million in Q4 2021.
  • Median Accumulated Depreciation over the past 5 years was $20.3 million (2023), compared with a mean of $20.8 million.
  • Biggest five-year swings in Accumulated Depreciation: rose 18.93% in 2021 and later increased 13.62% in 2022.
  • Ocular Therapeutix's Accumulated Depreciation stood at $15.2 million in 2021, then grew by 13.62% to $17.3 million in 2022, then grew by 17.26% to $20.3 million in 2023, then grew by 16.64% to $23.6 million in 2024, then grew by 16.45% to $27.5 million in 2025.
  • The last three reported values for Accumulated Depreciation were $27.5 million (Q4 2025), $23.6 million (Q4 2024), and $20.3 million (Q4 2023) per Business Quant data.